We aimed to analyze the expression status of TSP50 in CRCs compared with colorectal adenomas and normal tissues, determine its relationship with clinicopathological parameters, and investigate its prognostic value for CRC patients based on tumor stage (early and advanced stage). Here, PRSS50 is linked to colorectal carcinoma.